Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 to 70

Anrikefon versus nalbuphine for pain control after eye surgery

Official title: Efficacy and Safety of Anrikefon for Postoperative Analgesia in Ophthalmic Surgery: A Multicenter, Randomized, Parallel-Control, Non-Inferiority Trial

Run by Zhongshan Ophthalmic Center, Sun Yat-sen University · NCT07269106 · Data updated 2026-11-12

This trial will test whether Anrikefon provides pain relief as well as nalbuphine for adults having eye surgery under general anesthesia.

More Postoperative Pain Management trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment204 (estimated)
SponsorZhongshan Ophthalmic Center, Sun Yat-sen University
Academic / other
Locations3 sites (Guangzhou, Guangdong and 2 other locations)
StatusRecruiting
StartedJanuary 22, 2026
Main results expectedDecember 31, 2027
Study endsDecember 31, 2027
Registry record updatedApril 1, 2026
Trial IDNCT07269106 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–70 years old with ASA physical status I–III, BMI 18–30 kg/m², scheduled for ophthalmic surgery under general anesthesia who can give written informed consent are ideal candidates.

Probably not a fit

Patients with recent cardiovascular or cerebrovascular events, severe respiratory disease, major neurological or psychiatric disorders, known allergy to kappa opioid agonists or the anesthetic agents used in the study, or other listed exclusion conditions (such as active peptic ulcer disease) are unlikely to benefit and are excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults aged 18–70 undergoing ophthalmic surgery under general anesthesia will receive an intravenous dose of either Anrikefon or nalbuphine during the perioperative period and will be followed for pain, side effects, and recovery. The phase 4 interventional comparison is designed to determine whether Anrikefon is not inferior to nalbuphine for postoperative analgesia while producing fewer central side effects such as sedation or dizziness. Researchers will record pain scores, adverse events, and recovery metrics including time to discharge after day-surgery procedures, with follow-up assessments to capture safety and recovery outcomes. Results will help determine if Anrikefon can offer effective and safer perioperative pain management for ophthalmic day-surgery patients.

Why it matters

Potential benefit: If successful, Anrikefon could provide effective postoperative pain relief with fewer central nervous system side effects and potentially faster recovery and discharge for eye surgery patients.

How similar studies have gone: Nalbuphine is an established option for perioperative analgesia, while kappa-opioid agents like Anrikefon have been explored in other settings but have limited published data specifically in ophthalmic day-surgery.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Scheduled for ophthalmic surgery under general anesthesia.
* Aged 18 to 70 years.
* With American Society of Anesthesiologists (ASA) physical status I to III.
* Body mass index (BMI) between 18 and 30 kg/m²
* Agree to participate in the trial and provide written informed consent.

Exclusion Criteria:

* History of cardiovascular or cerebrovascular events within the past 6 months, including unstable angina, ischemic myocardial infarction, or heart failure; or current presence of uncontrolled hypertension (\>180/110 mmHg), aneurysm, or severe cardiac arrhythmia.
* Severe respiratory diseases such as pulmonary fibrosis, severe pulmonary abscess, cor pulmonale, or advanced chronic obstructive pulmonary disease (COPD).
* Significant neurological disorders such as brain injury or seizures, as well as severe psychiatric illnesses.
* Known allergy to kappa opioid receptor agonists or to general anesthetic agents used in this study.
* Current peptic ulcer disease, gastrointestinal bleeding, or known hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs), such as flurbiprofen axetil or paracetamol.
* Prior use of opioid or non-opioid analgesics, with the last administration occurring within five half-life periods of the drug.
* Continuous use of opioid analgesics for more than 10 days within the 3 months prior to screening.
* Use of drugs with unknown half-life periods that may affect analgesic efficacy within 14 days before randomization.
* History of major surgery within the past 3 months that may interfere with postoperative pain assessment.

Where it's running

  • Zhongshan Ophthalmic Center, Sun Yat-Sen University
    Guangzhou, Guangdong, China
    Recruiting
  • The Affiliated Hospital of Yunnan University
    Kunming, Yunnan, China
    Not yet recruiting
  • Eye & ENT Hospital of Fudan University
    Shanghai, China
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Lower vs higher ketamine doses to reduce the oculocardiac reflex in eye surgery

    A single-dose comparison tests whether 0.5 mg/kg IV ketamine works as well as 0.75 mg/kg IV for lowering the oculocardiac reflex in adults having eye surgery.

    Recruiting Cairo University · Cairo · NCT07708740

  • Postoperative Pain Management in Thoracic Surgery

    This study tests how well pain control methods work after thoracic surgery for adults, especially when epidural analgesia isn’t possible.

    Recruiting Hospital Universitario de Gran Canaria Doctor Negrín · Las Palmas de Gran Canaria, Las Palmas · NCT07694141

  • Comparison of two chest wall blocks for pain after VATS

    Doctors test whether the rhomboid intercostal plane block or the SPSIP block better relieves pain after video-assisted thoracoscopic surgery in adults.

    Recruiting Cumhuriyet University · Sivas, Merkez and 1 other locations · NCT07524673

  • mTLIP versus QIPB for pain relief after lumbar microdiscectomy

    This study will test whether the modified thoracolumbar interfascial plane block (mTLIP) or the quadro-iliac plane block (QIPB) provides better pain relief for adults having lumbar microdiscectomy surgery.

    Recruiting Bursa City Hospital · Bursa, Nilüfer · NCT07480278

  • Sensory mapping of two nerve blocks for laparoscopic gallbladder surgery

    We will test whether two regional nerve blocks (External Oblique Plane and Serratus Intercostal Plane) produce different skin numbness patterns in adults having elective laparoscopic gallbladder removal.

    Recruiting Samsun University · Samsun, Ilkadım · NCT07445854

  • Continuous nefopam infusion after pancreatoduodenectomy

    This trial will test whether a continuous infusion of nefopam can lower opioid use and reduce pain for people having a pancreatoduodenectomy.

    Recruiting Phase 4 Iuliu Hatieganu University of Medicine and Pharmacy · Cluj-Napoca, Cluj · NCT07423650

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.